Literature DB >> 20156932

Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device.

Paul J M Sessink1, Thomas H Connor, James A Jorgenson, Timothy G Tyler.   

Abstract

PURPOSE: Surface contamination with the antineoplastic drugs cyclophosphamide, ifosfamide, and 5-fluorouracil was compared in 22 US hospital pharmacies following preparation with standard drug preparation techniques or the PhaSeal® closed-system drug transfer device (CSTD).
METHODS: Wipe samples were taken from biological safety cabinet (BSC) surfaces, BSC airfoils, floors in front of BSCs, and counters and analyzed for contamination with cyclophosphamide, ifosfamide, and 5-fluorouracil. Contamination was reassessed several months after the implementation of the CSTD. Surface contamination (ng/cm(2)) was compared between the two techniques and evaluated with the Signed Rank Test.
RESULTS: Using the CSTD compared to the standard preparation techniques, a significant reduction in levels of contamination was observed for all drugs (cyclophosphamide: p < 0.0001; ifosfamide: p < 0.001; 5-fluorouracil: p < 0.01). Median values for surface contamination with cyclophosphamide, ifosfamide, and 5-fluorouracil were reduced by 95%, 90%, and 65%, respectively.
CONCLUSIONS: Use of the CSTD significantly reduces surface contamination when preparing cyclophosphamide, ifosfamide, and 5-fluorouracil as compared to standard drug preparation techniques.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20156932      PMCID: PMC4627487          DOI: 10.1177/1078155210361431

Source DB:  PubMed          Journal:  J Oncol Pharm Pract        ISSN: 1078-1552            Impact factor:   1.809


  58 in total

Review 1.  Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods.

Authors:  Roberta Turci; Cristina Sottani; Giuseppe Spagnoli; Claudio Minoia
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-06-15       Impact factor: 3.205

2.  Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies.

Authors:  Thomas H Connor; Paul J M Sessink; Bruce R Harrison; Jack R Pretty; Byron G Peters; Raul M Alfaro; Appie Bilos; Gwendolyn Beckmann; Michael R Bing; Lakisha M Anderson; Robert Dechristoforo
Journal:  Am J Health Syst Pharm       Date:  2005-03-01       Impact factor: 2.637

3.  Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden.

Authors:  M Hedmer; A Georgiadi; E Rämme Bremberg; B A G Jönsson; S Eksborg
Journal:  Ann Occup Hyg       Date:  2005-08-26

4.  Occupational exposure to antineoplastic agents: self-reported miscarriages and stillbirths among nurses and pharmacists.

Authors:  B Valanis; W M Vollmer; P Steele
Journal:  J Occup Environ Med       Date:  1999-08       Impact factor: 2.162

5.  Urinary cyclophosphamide assay as a method for biological monitoring of occupational exposure to cyclophosphamide.

Authors:  C T Evelo; R P Bos; J G Peters; P T Henderson
Journal:  Int Arch Occup Environ Health       Date:  1986       Impact factor: 3.015

6.  Biological and environmental monitoring of occupational exposure to cyclophosphamide in industry and hospitals.

Authors:  M Sorsa; L Pyy; S Salomaa; L Nylund; J W Yager
Journal:  Mutat Res       Date:  1988-03       Impact factor: 2.433

Review 7.  Bladder cancer in a 39-year-old female pharmacist.

Authors:  L I Levin; E A Holly; J P Seward
Journal:  J Natl Cancer Inst       Date:  1993-07-07       Impact factor: 13.506

8.  Determination of methotrexate in environmental samples by solid phase extraction and high performance liquid chromatography: ultraviolet or tandem mass spectrometry detection?

Authors:  R Turci; G Micoli; C Minoia
Journal:  Rapid Commun Mass Spectrom       Date:  2000       Impact factor: 2.419

9.  Maternal occupational risk factors for oral clefts. Occupational Exposure and Congenital Malformation Working Group.

Authors:  C Lorente; S Cordier; A Bergeret; H E De Walle; J Goujard; S Aymé; R Knill-Jones; E Calzolari; F Bianchi
Journal:  Scand J Work Environ Health       Date:  2000-04       Impact factor: 5.024

10.  Leukaemia and reproductive outcome among nurses handling antineoplastic drugs.

Authors:  T Skov; B Maarup; J Olsen; M Rørth; H Winthereik; E Lynge
Journal:  Br J Ind Med       Date:  1992-12
View more
  34 in total

Review 1.  Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: a review of the evidence.

Authors:  Thomas H Connor; Christina C Lawson; Martha Polovich; Melissa A McDiarmid
Journal:  J Occup Environ Med       Date:  2014-09       Impact factor: 2.162

2.  Field evaluation of onsite near real-time monitors for surface contamination by 5-fluorouracil.

Authors:  Jerome P Smith; Deborah Sammons; Shirley Robertson; Edward Krieg; John Snawder
Journal:  J Oncol Pharm Pract       Date:  2018-06-27       Impact factor: 1.809

3.  Factors Influencing Nurses' Use of Hazardous Drug Safe-Handling Precautions.

Authors:  Amy Callahan; Nancy J Ames; Mary Lou Manning; Kate Touchton-Leonard; Li Yang; Gwenyth Wallen
Journal:  Oncol Nurs Forum       Date:  2016-05-01       Impact factor: 2.172

4.  Safe handling of cytotoxics: guideline recommendations.

Authors:  A C Easty; N Coakley; R Cheng; M Cividino; P Savage; R Tozer; R E White
Journal:  Curr Oncol       Date:  2015-02       Impact factor: 3.677

Review 5.  Environmental monitoring by surface sampling for cytotoxics: a review.

Authors:  Petit Marie; Curti Christophe; Roche Manon; Montana Marc; Bornet Charleric; Vanelle Patrice
Journal:  Environ Monit Assess       Date:  2017-01-06       Impact factor: 2.513

6.  Multicenter study of environmental contamination with antineoplastic drugs in 33 Canadian hospitals.

Authors:  Delphine Merger; Cynthia Tanguay; Eric Langlois; Michel Lefebvre; Jean-François Bussières
Journal:  Int Arch Occup Environ Health       Date:  2013-03-08       Impact factor: 3.015

7.  Environmental contamination with hazardous drugs in quebec hospitals.

Authors:  Jean-François Bussières; Cynthia Tanguay; Karine Touzin; Eric Langlois; Michel Lefebvre
Journal:  Can J Hosp Pharm       Date:  2012-11

8.  Causes of Health Care Workers' Exposure to Antineoplastic Drugs: An Exploratory Study.

Authors:  Chun-Yip Hon; Dina Abusitta
Journal:  Can J Hosp Pharm       Date:  2016-06-30

9.  Review of economic data on closed system transfer drug for preparation and administration of hazardous drugs.

Authors:  Annaelle Soubieux; Cynthia Tanguay; Jean Lachaine; Jean-François Bussières
Journal:  Eur J Hosp Pharm       Date:  2019-02-22

10.  Reduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer Device.

Authors:  Paul J M Sessink; Jason Trahan; Joseph W Coyne
Journal:  Hosp Pharm       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.